Rodger et al reported the HERDOO2 score to evaluate a woman with a history of unprovoked venous thromboembolism. This can help to decide if oral anticoagulants should be continued or discontinued. The authors are from the University of Ottawa and multiple hospitals in Canada and the United States.
Patient selection: woman with unprovoked venous thromboembolism who has been receiving oral anticoagulants for 5-7 months with no recurrence while on therapy
Component of the HERDOO2 score:
(1) HER for post-thrombotic signs of hyperpigmentation, edema, redness of either leg
(2) D for D-Dimer using the Vidas D-dimer test (bio-Merieux)
(3) for obesity based on body mass index (BMI)
(4) for older age
Parameter |
Finding |
Points |
HER findings |
absent |
0 |
|
present |
1 |
D-dimer |
< 250 µg/L |
0 |
|
>= 250 µg/L |
1 |
body mass index |
< 30 kg per square meter |
0 |
|
>= 30 kg per square meter |
1 |
age |
< 65 years |
0 |
|
>= 65 years |
1 |
score =
= SUM(points for all 4 parameters)
Interpretation:
• minimum score: 0
• maximum score: 4
• The higher the score the greater the need to continue oral anticoagulant therapy.
• A patient with a score of 0 or 1 may be able to discontinue anticoagulant therapy.
X =
= (1.2977 * (points for BMI)) + (0.6473 * (points for HER)) + (0.9155 * (points for D-dimer)) + (0.8084 * (points for age)) –3.9717
probability of recurrent venous thromboembolism =
= 1 / (1 + EXP((-1) * X))
Specialty: Hematology Oncology, Clinical Laboratory, Pharmacology, clinical